Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)

Japan flag Japan · Delayed Price · Currency is JPY
44.00
+1.00 (2.33%)
Jun 13, 2025, 3:30 PM JST
-38.03%
Market Cap 2.51B
Revenue (ttm) 29.40M
Net Income (ttm) -1.25B
Shares Out 58.40M
EPS (ttm) -22.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 197,100
Average Volume 155,805
Open 43.00
Previous Close 43.00
Day's Range 42.00 - 44.00
52-Week Range 38.00 - 94.00
Beta 0.58
RSI 47.23
Earnings Date Aug 14, 2025

About TYO:4596

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices; and wearable device for myopia c... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 19
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4596
Full Company Profile

Financial Performance

In 2024, TYO:4596's revenue was 27.00 million, a decrease of -30.77% compared to the previous year's 39.00 million. Losses were -1.33 billion, -10.54% less than in 2023.

Financial Statements

News

There is no news available yet.